Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)
China flag China · Delayed Price · Currency is CNY
3.220
-0.190 (-5.57%)
Aug 27, 2026, 3:00 PM CST

SHA:600165 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
272.49460.658.6124.489.48110.95
Cash & Short-Term Investments
272.49460.658.6124.489.48110.95
Cash Growth
1829.95%5252.30%-64.73%-72.73%-19.35%-46.46%
Accounts Receivable
118.41110.3869.8460.363521.74
Other Receivables
87.4437.315.243.352.491.58
Receivables
205.85147.6975.0763.7137.4923.32
Inventory
173.02117.28102.0595.83109.31144.97
Prepaid Expenses
-9.348.870.340.01-
Other Current Assets
60.656.8119.6414.4215.5732.91
Total Current Assets
711.96791.77214.24198.7251.86312.16
Property, Plant & Equipment
1,6141,6201,8081,8722,1982,231
Long-Term Investments
---710.41672.17652.02
Other Intangible Assets
59.3260.2767.1474.3179.352.53
Long-Term Deferred Tax Assets
2.142.164.553.052.96.09
Long-Term Deferred Charges
3.613.85.076.236.87.65
Other Long-Term Assets
14.2612.2967.9992.8167.5344.37
Total Assets
2,4062,4902,1672,9583,2793,306

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
118.6115.96820.22635.36692.24567.22
Accrued Expenses
2.3328.44143.15123.8718.5824.6
Short-Term Debt
7.217.81674.32532.24461.67344.19
Current Portion of Long-Term Debt
2.642.15-424.53369.5474.2
Current Portion of Leases
-0.521.661.230.750.32
Current Income Taxes Payable
7.992.63--0.740.02
Current Unearned Revenue
4.723.33.278.054.1856.45
Other Current Liabilities
119.7124.82254.87155.7818.8313.04
Total Current Liabilities
263.2285.631,8981,8811,5671,080
Long-Term Debt
851.42845.98-743.8781.51,079
Long-Term Leases
-0.91.291.71.531.86
Long-Term Unearned Revenue
16.8319.4917.6318.2619.912.91
Long-Term Deferred Tax Liabilities
1.932.032.523.063.23.65
Other Long-Term Liabilities
--7.913.9611.9764.47
Total Liabilities
1,1331,1541,9272,6522,3852,242

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,6161,616684.88684.88684.88684.88
Additional Paid-In Capital
1,2531,253957.74442.27442.04441.79
Retained Earnings
-1,726-1,661-1,571-1,032-497.71-356.23
Comprehensive Income & Other
---3.930.1-0.12
Total Common Equity
1,1441,20871.7999.16629.31770.32
Minority Interest
128.58128.07168.37206.5264.77293.4
Shareholders' Equity
1,2721,336240.17305.65894.081,064
Total Liabilities & Equity
2,4062,4902,1672,9583,2793,306

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
861.27857.36677.271,7041,6151,500
Net Cash (Debt)
-588.78-396.71-668.67-1,679-1,526-1,389
Net Cash Growth
------
Net Cash Per Share
-0.32-0.25-0.98-2.45-2.23-2.03
Filing Date Shares Outstanding
1,6161,616684.88684.88684.88684.88
Total Common Shares Outstanding
1,6161,616684.88684.88684.88684.88
Working Capital
448.77506.14-1,683-1,682-1,315-767.88
Book Value Per Share
0.710.750.100.140.921.12
Tangible Book Value
1,0841,1484.6524.84550.01717.79
Tangible Book Value Per Share
0.670.710.010.040.801.05
Buildings
-552.92643.45669.89767.23607.44
Machinery
-1,5821,5791,5211,6231,078
Construction In Progress
-81.3979.4372.7974.65696.41